Yogesh Srivastava
Yogesh Srivastava
MD Anderson Cancer Research
Adresse e-mail validée de mdanderson.org
Titre
Citée par
Citée par
Année
Molecular basis for the genome engagement by Sox proteins
L Hou, Y Srivastava, R Jauch
Seminars in cell & developmental biology 63, 2-12, 2017
612017
Cervical cancer stem cells selectively overexpress HPV oncoprotein E6 that controls stemness and self-renewal through upregulation of HES1
A Tyagi, K Vishnoi, S Mahata, G Verma, Y Srivastava, S Masaldan, ...
Clinical Cancer Research 22 (16), 4170-4184, 2016
552016
Alterations in microRNAs miR-21 and let-7a correlate with aberrant STAT3 signaling and downstream effects during cervical carcinogenesis
G Shishodia, S Shukla, Y Srivastava, S Masaldan, S Mehta, S Bhambhani, ...
Molecular cancer 14 (1), 1-13, 2015
512015
Deregulation of microRNAs Let-7a and miR-21 mediate aberrant STAT3 signaling during human papillomavirus-induced cervical carcinogenesis: role of E6 oncoprotein
G Shishodia, G Verma, Y Srivastava, R Mehrotra, BC Das, AC Bharti
BMC cancer 14 (1), 1-13, 2014
492014
Mutations involving the SRY-related gene SOX8 are associated with a spectrum of human reproductive anomalies
MF Portnoi, MC Dumargne, S Rojo, SF Witchel, AJ Duncan, C Eozenou, ...
Human molecular genetics 27 (7), 1228-1240, 2018
352018
Structure and decoy-mediated inhibition of the SOX18/Prox1-DNA interaction
M Klaus, N Prokoph, M Girbig, X Wang, YH Huang, Y Srivastava, L Hou, ...
Nucleic acids research 44 (8), 3922-3935, 2016
302016
Cervical cancer stem cells manifest radioresistance: Association with upregulated AP-1 activity
A Tyagi, K Vishnoi, H Kaur, Y Srivastava, BG Roy, BC Das, AC Bharti
Scientific reports 7 (1), 1-14, 2017
202017
Cervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using “screen and treat” approach
S Joshi, V Kulkarni, T Darak, U Mahajan, Y Srivastava, S Gupta, ...
International Journal of Women's Health 7, 477, 2015
202015
In vitro evaluation of antimicrobial properties of Carica papaya
JA Khan, J Yadav, Y Srivastava, PK Pal
International Journal of Biology, Pharmacy and Allied Sciences 1 (7), 933-945, 2012
202012
Quantitative profiling of selective Sox/POU pairing on hundreds of sequences in parallel by Coop-seq
YK Chang, Y Srivastava, C Hu, A Joyce, X Yang, Z Zuo, JJ Havranek, ...
Nucleic acids research 45 (2), 832-845, 2017
172017
Pluripotency reprogramming by competent and incompetent POU factors uncovers temporal dependency for Oct4 and Sox2
V Malik, LV Glaser, D Zimmer, S Velychko, M Weng, M Holzner, M Arend, ...
Nature communications 10 (1), 1-16, 2019
142019
SOX17 in cellular reprogramming and cancer
DS Tan, M Holzner, M Weng, Y Srivastava, R Jauch
Seminars in Cancer Biology, 2019
102019
Directed evolution of reprogramming factors by cell selection and sequencing
V Veerapandian, JO Ackermann, Y Srivastava, V Malik, M Weng, X Yang, ...
Stem cell reports 11 (2), 593-606, 2018
82018
DNA-mediated dimerization on a compact sequence signature controls enhancer engagement and regulation by FOXA1
X Wang, Y Srivastava, A Jankowski, V Malik, Y Wei, RC Del Rosario, ...
Nucleic acids research 46 (11), 5470-5486, 2018
52018
The crystal structure of a maxi/mini-ferritin chimera reveals guiding principles for the assembly of protein cages
TA Cornell, Y Srivastava, R Jauch, R Fan, BP Orner
Biochemistry 56 (30), 3894-3899, 2017
42017
Coop-Seq analysis demonstrates that Sox2 evokes latent specificities in the DNA recognition by Pax6
C Hu, V Malik, YK Chang, V Veerapandian, Y Srivastava, YH Huang, ...
Journal of Molecular Biology 429 (23), 3626-3634, 2017
32017
Cancer‐associated missense mutations enhance the pluripotency reprogramming activity of OCT4 and SOX17
Y Srivastava, DS Tan, V Malik, M Weng, A Javed, V Cojocaru, G Wu, ...
The FEBS journal 287 (1), 122-144, 2020
12020
SOX17 in cellular reprogramming and cancer.
TD Senna, M Holzner, M Weng, Y Srivastava, R Jauch
Seminars in cancer biology, 2019
2019
Understanding mechanisms behind cell fate reprogramming through a highly efficient artificially evolved POU factor (ePOU)
DSY TAN, YP Chen, AH Bednarz, V Malik, YJ Wei, S Velychko, ...
3rd Retreat of the Max Planck GIBH Centre for Regenerative Biomedicine …, 2019
2019
Decoding the molecular basis for the functional improvement of re-engineered pluripotency reprogramming factors
DS Tan, Y Srivastava, M Weng, Y Chen, Y Wei, R Jauch
Research Postgraduates Poster Presentation Session, School of Biomedical …, 2019
2019
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20